Toth Financial Advisory
BBOT icon

Toth Financial Advisory’s BridgeBio Oncology BBOT Stock Holding History

Toth Financial Advisory’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.56K Buy
+1,600
New +$12.4K ﹤0.01% 635

Other funds holding BBOT

Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Toth Financial Advisory's BBOT Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 1,600 shares worth $6.56K. The stake represents ﹤0.01% of the portfolio and ranks #635 among its holdings.

7 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • Toth Financial Advisory held 1,600 shares of BridgeBio Oncology worth $6.56K as of Q3 2026.
  • BridgeBio Oncology was a new Toth Financial Advisory position in Q3 2026.
  • BridgeBio Oncology made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #635 holding.
  • 7 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.